Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
CD Protein Inhibitors
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
15
30
45
60
75
90
105
120
135
150
Rituxan
(rituximab) / Roche
Orencia
(abatacept) / BMS
Promacta
(eltrombopag) / Novartis
Zinbryta
(daclizumab) / Biogen, AbbVie
Epratucyn
(epratuzumab) / Gilead
Campath
(alemtuzumab) / Sanofi
Lemtrada
(alemtuzumab) / Sanofi
Simulect
(basiliximab) / Novartis
Ocrevus
(ocrelizumab) / Roche
otelixizumab
(ChAglyCD3) / GSK
Arzerra
(ofatumumab) / Novartis, Genmab
Nulojix
(belatacept) / BMS
PF-5230895
/ Emergent Biosolutions, Pfizer
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Raptiva
(efalizumab) / Roche, EMD Serono, Xoma
Tzield
(teplizumab-mzwv) / Sanofi
tregalizumab
(BT-061) / ADMA Biologics, T-Balance Therapeutics
Rixathon
(rituximab biosimilar) / Kyowa Kirin, Sandoz
dapirolizumab pegol
(CDP7657) / Biogen, UCB, Nektar Therap
Amevive
(alefacept) / Astellas
HuMax-CD4
(zanolimumab) / Emergent Biosolutions
Lupuzor
(rigerimod) / ImmuPharma, Alora Pharma
MDX-1342
/ BMS
MK-8808
(rituximab biosimilar) / Merck (MSD)
MTRX 1011A
/ Tolerx, Roche
Ruxience
(rituximab-pvvr) / Pfizer
TRU-015
/ Pfizer
Uplizna
(inebilizumab-cdon) / Mitsubishi Tanabe, Amgen
Veltucyn
(veltuzumab) / Gilead
pepinemab
(VX15) / Vaccinex
